Concepedia

Bijal Shah

BS

111

Publications

6.8K

Citations

39

H-Index

1992

Active since

Affiliations

Moffitt Cancer Center(Current)

The University of Texas MD Anderson Cancer Center

University of South Florida

Dana-Farber Cancer Institute

Memorial Sloan Kettering Cancer Center

Bijal Shah is an author at Moffitt Cancer Center specializing in medicine, oncology, and immunology.

ORCID

Top concepts

Publications per year

1992–2025

111

Publications

111

KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study

Bijal Shah, Armin Ghobadi, Olalekan O. Oluwole et al. · The Lancet · 2021 · 721 citations · Full text

, , +9

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial

Michael Wang, Simon Rule, Pier Luigi Zinzani et al. · The Lancet · 2017 · 428 citations · Full text

, , +2

Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)

Raza M. Alvi, Matthew J. Frigault, Michael G. Fradley et al. · Journal of the American College of Cardiology · 2019 · 328 citations · Full text

Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma

Michael D. Jain, Hua Zhao, Xuefeng Wang et al. · Blood · 2021 · 273 citations · Full text

Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma

Jennifer M. Logue, Elisa Zucchetti, Christina A. Bachmeier et al. · Haematologica · 2020 · 260 citations · Full text

Rows per page

1–5 of 111